Market Cap 11.48M
Revenue (ttm) 0.00
Net Income (ttm) -10.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 147,800
Avg Vol 333,836
Day's Range N/A - N/A
Shares Out 13.67M
Stochastic %K 33%
Beta 1.58
Analysts Sell
Price Target $10.17

Company Profile

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 9 799 6183
Address:
Building B, 11 HaMenofim Street, Herzliya, Israel
ValleyCapital
ValleyCapital Dec. 24 at 6:46 PM
$NRSN coal for Christmas
0 · Reply
BioRich
BioRich Dec. 24 at 4:56 PM
$NRSN Still strong on NRSN. Hasn't been pretty, but I still believe there's a lot of opportunity here. Keep the faith folks. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers!
1 · Reply
Megaloblatta_Longipennis
Megaloblatta_Longipennis Dec. 24 at 4:54 PM
$NRSN a partnership has fallen through. Thats not a hiccup. Thats an all out fail
0 · Reply
mmtiddy
mmtiddy Dec. 24 at 3:07 PM
$NRSN Day 365, its been a year hearing these CEO lies! Happy anniversary
0 · Reply
QuartzQuant
QuartzQuant Dec. 24 at 11:46 AM
$NRSN Expectations are now anchored to how internal discipline offsets macro and competitive headwinds. Delays or dilution could materially reshape the risk profile.
0 · Reply
bourne86
bourne86 Dec. 24 at 11:11 AM
$NRSN waiting to see price action after Dec 30 special meeting with RSU's to be voted on. I think it will pass so I believe there will be dilution soon after.
1 · Reply
Speculator2
Speculator2 Dec. 24 at 4:15 AM
$NRSN This will get bought out, sooner than later. The partnership deal is likely caduque, and they might be about to be acquired. Alone, that cannot make it through phase 3.
0 · Reply
funnymoney90210
funnymoney90210 Dec. 24 at 12:55 AM
$NRSN haha told yall investors wanted out today
0 · Reply
Fighting_ALS
Fighting_ALS Dec. 23 at 3:00 PM
$NRSN Very BULLISH
0 · Reply
supernoob
supernoob Dec. 23 at 2:44 PM
$NRSN We're goin' up, up, up, it's our moment You know together we're glowin' Gonna be, gonna be golden
0 · Reply
Latest News on NRSN
NeuroSense to Host Investor Webinar on December 8, 2025

Nov 3, 2025, 9:15 AM EST - 7 weeks ago

NeuroSense to Host Investor Webinar on December 8, 2025


NeuroSense Announces First Quarter 2024 Business Update

May 2, 2024, 9:19 AM EDT - 1 year ago

NeuroSense Announces First Quarter 2024 Business Update


ValleyCapital
ValleyCapital Dec. 24 at 6:46 PM
$NRSN coal for Christmas
0 · Reply
BioRich
BioRich Dec. 24 at 4:56 PM
$NRSN Still strong on NRSN. Hasn't been pretty, but I still believe there's a lot of opportunity here. Keep the faith folks. Follow/Subscribe for more suggestions and perspective. Would love to hear yours too. That's how we find these gems and learn. Let's make some money. Cheers!
1 · Reply
Megaloblatta_Longipennis
Megaloblatta_Longipennis Dec. 24 at 4:54 PM
$NRSN a partnership has fallen through. Thats not a hiccup. Thats an all out fail
0 · Reply
mmtiddy
mmtiddy Dec. 24 at 3:07 PM
$NRSN Day 365, its been a year hearing these CEO lies! Happy anniversary
0 · Reply
QuartzQuant
QuartzQuant Dec. 24 at 11:46 AM
$NRSN Expectations are now anchored to how internal discipline offsets macro and competitive headwinds. Delays or dilution could materially reshape the risk profile.
0 · Reply
bourne86
bourne86 Dec. 24 at 11:11 AM
$NRSN waiting to see price action after Dec 30 special meeting with RSU's to be voted on. I think it will pass so I believe there will be dilution soon after.
1 · Reply
Speculator2
Speculator2 Dec. 24 at 4:15 AM
$NRSN This will get bought out, sooner than later. The partnership deal is likely caduque, and they might be about to be acquired. Alone, that cannot make it through phase 3.
0 · Reply
funnymoney90210
funnymoney90210 Dec. 24 at 12:55 AM
$NRSN haha told yall investors wanted out today
0 · Reply
Fighting_ALS
Fighting_ALS Dec. 23 at 3:00 PM
$NRSN Very BULLISH
0 · Reply
supernoob
supernoob Dec. 23 at 2:44 PM
$NRSN We're goin' up, up, up, it's our moment You know together we're glowin' Gonna be, gonna be golden
0 · Reply
mmtiddy
mmtiddy Dec. 23 at 1:46 PM
$NRSN Can someone explain why this jumped to $0.95 and dropped back to $0.85 immediately Someone probably bought the wrong stock
1 · Reply
mmtiddy
mmtiddy Dec. 23 at 1:40 PM
$NRSN why is this up??
0 · Reply
funnymoney90210
funnymoney90210 Dec. 23 at 12:46 AM
$NRSN The are pumping out BS news thinking it will help their stuck investors...investors want out at 96 cents...ooops
0 · Reply
ValleyCapital
ValleyCapital Dec. 22 at 5:06 PM
$NRSN can we get a Santa Claus rally here
0 · Reply
JohnTrack
JohnTrack Dec. 22 at 4:37 PM
$NRSN Confirms Favorable Safety and Tolerability of PrimeC in an Alzheimer's Phase 2 Study https://www.rapidticker.com/news/nrsn-neurosense-confirms-favorable-safety-and-9f9781
0 · Reply
JarvisFlow
JarvisFlow Dec. 22 at 4:00 PM
D. Boral Capital updates rating for NeuroSense Therapeutics ( $NRSN ) to Buy, target set at 14.
0 · Reply
supernoob
supernoob Dec. 22 at 2:51 PM
$NRSN stay and pray
0 · Reply
lev57
lev57 Dec. 22 at 2:40 PM
$NRSN the data, the trials, and the FDA review are great. You can't take that away from them. A few hiccups and delays won't stop them . You forget that the business world is a jungle. Everyone wants to trip up the other. Expect surprises. We are optimistic and not resentful. We believe in the company and its achievements. It has supporting evidence from hospitals and senior doctors. Even though they are not meeting the goals they thought they would meet. The business world is a jungle. We will reach the goal even on the long road for the sake of patients They presented positive data and they are moving forward.
0 · Reply
DARKP00L
DARKP00L Dec. 22 at 2:23 PM
$NRSN 09:20 on Dec. 22 2025 NeuroSense Therapeutics' Analysis From Phase 2 NST-AD-001 Trial Of PrimeC Combination In Alzheimer's Demonstrates Favorable Tolerability For PrimeC #tradeideas
0 · Reply
Stock_Catcher
Stock_Catcher Dec. 22 at 2:18 PM
$NRSN NeuroSense Confirms Favorable Safety and Tolerability of PrimeC in an Alzheimer's Phase 2 Study
0 · Reply
mmtiddy
mmtiddy Dec. 22 at 2:11 PM
$NRSN Day 363, almost a year! Don’t forget to vote to award the board more shares because they can’t pay salaries 🤭
0 · Reply
elmono
elmono Dec. 20 at 9:56 AM
$GLMD $NRSN $SGMO still not failing 😂😂
0 · Reply